These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 8919277

  • 1. Stimulation of decreased lipoprotein lipase activity in the tumor-bearing state by the antihyperlipidemic drug bezafibrate.
    Nomura K, Noguchi Y, Matsumoto A.
    Surg Today; 1996; 26(2):89-94. PubMed ID: 8919277
    [Abstract] [Full Text] [Related]

  • 2. Role of insulin resistance in decreasing lipoprotein lipase activity in tumor-bearing rats.
    Noguchi Y, Nomura K, Yoshikawa T, Fukuzawa K, Makino T, Tsuburaya A, Matsumoto A.
    Surg Today; 1996; 26(4):271-5. PubMed ID: 8727949
    [Abstract] [Full Text] [Related]

  • 3. Tumor-induced alterations in tissue lipoprotein lipase activity and mRNA levels.
    Noguchi Y, Vydelingum NA, Younes RN, Fried SK, Brennan MF.
    Cancer Res; 1991 Feb 01; 51(3):863-9. PubMed ID: 1988126
    [Abstract] [Full Text] [Related]

  • 4. Effect of lipoprotein lipase activators bezafibrate and NO-1886, on B16 melanoma-induced cachexia in mice.
    Kawamura I, Yamamoto N, Sakai F, Yamazaki H, Goto T.
    Anticancer Res; 1999 Feb 01; 19(5B):4099-103. PubMed ID: 10628360
    [Abstract] [Full Text] [Related]

  • 5. [Stimulation of tissue lipoprotein lipase activity in cancer cachectic rats: preliminary report].
    Nomura K, Noguchi Y, Yoshikawa T, Fukuzawa K, Tuburaya A, Yoshida S, Matsumoto A.
    Nihon Geka Gakkai Zasshi; 1993 Jul 01; 94(7):759. PubMed ID: 8361478
    [No Abstract] [Full Text] [Related]

  • 6. Ultrastructural alterations of hepatocytes in the tumour-bearing, cachectic rat.
    Makino T, Noguchi Y, Ito T, Matsumoto A.
    Int J Exp Pathol; 1994 Dec 01; 75(6):433-40. PubMed ID: 7734332
    [Abstract] [Full Text] [Related]

  • 7. Suppression of carcass weight loss in cachexia in rats bearing Leydig cell tumor by the novel compound NO-1886, a lipoprotein lipase activator.
    Ohara M, Tsutsumi K, Ohsawa N.
    Metabolism; 1998 Jan 01; 47(1):101-5. PubMed ID: 9440486
    [Abstract] [Full Text] [Related]

  • 8. Opposite effects of bezafibrate and gemfibrozil in both normal and hypertriglyceridemic rats.
    Krause BR, Barnett BC, Essenburg AD, Kieft KA, Auerbach BJ, Bousley R, Stanfield R, Newton RS, Bisgaier CL.
    Atherosclerosis; 1996 Nov 15; 127(1):91-101. PubMed ID: 9006809
    [Abstract] [Full Text] [Related]

  • 9. Effects of treatment with bezafibrate on lipoprotein lipase activity and mass in patients with hypertriglyceridemia.
    Kobayashi J, Takahashi K, Tashiro J, Shirai K, Saito Y, Yoshida S, Hashimoto H, Fukamachi I, Niihara K, Sasaki N.
    Arzneimittelforschung; 1994 Feb 15; 44(2):145-8. PubMed ID: 8147947
    [Abstract] [Full Text] [Related]

  • 10. Activation of lipoprotein lipase and inhibition of B16 melanoma-induced cachexia in mice by ponalrestat, an aldose reductase inhibitor.
    Kawamura I, Yamamoto N, Sakai F, Yamazaki H, Naoe Y, Inami M, Manda T, Shimomura K.
    Anticancer Res; 1999 Feb 15; 19(1A):341-8. PubMed ID: 10226565
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancement of preheparin serum lipoprotein lipase mass by bezafibrate administration.
    Totsuka M, Miyashita Y, Ito Y, Watanabe H, Murano T, Shirai K.
    Atherosclerosis; 2000 Nov 15; 153(1):175-9. PubMed ID: 11058713
    [Abstract] [Full Text] [Related]

  • 15. Energy depletion in the liver and in isolated hepatocytes of tumor-bearing animals.
    Tsuburaya A, Blumberg D, Burt M, Brennan MF.
    J Surg Res; 1995 Oct 15; 59(4):421-7. PubMed ID: 7564311
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma interleukin-6 is not a mediator of changes in lipoprotein lipase activity in cancer patients.
    Nomura K, Noguchi Y, Yoshikawa T, Kondo J.
    Hepatogastroenterology; 1997 Oct 15; 44(17):1519-26. PubMed ID: 9356883
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice.
    Inaba T, Yagyu H, Itabashi N, Tazoe F, Fujita N, Nagashima S, Okada K, Okazaki M, Furukawa Y, Ishibashi S.
    Hypertens Res; 2008 May 15; 31(5):999-1005. PubMed ID: 18712055
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.